Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Causal Inference and COVID-19 Nursing Home Patients: Identifying Factors That Reduced Mortality Risk

Ahmed et al., medRxiv, doi:10.1101/2021.11.18.21266489
Nov 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 10% Improvement Relative Risk Vitamin D for COVID-19  Ahmed et al.  Prophylaxis Is prophylaxis with vitamin D beneficial for COVID-19? Retrospective study in the USA Lower mortality with vitamin D (not stat. sig., p=0.28) c19early.org Ahmed et al., medRxiv, November 2021 Favorsvitamin D Favorscontrol 0 0.5 1 1.5 2+
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now with p < 0.00000000001 from 122 studies, recognized in 9 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
5,000+ studies for 104 treatments. c19early.org
Retrospective causal inference analysis of 4,091 COVID+ long-term care high risk patients in the USA, showing lower mortality with vitamin D, without statistical significance.
This is the 59th of 122 COVID-19 controlled studies for vitamin D, which collectively show efficacy with p<0.0000000001 (1 in 587 sextillion).
30 studies are RCTs, which show efficacy with p=0.0000032.
risk of death, 10.5% lower, RR 0.90, p = 0.28.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Ahmed et al., 21 Nov 2021, retrospective, USA, preprint, 5 authors, dosage not specified.
This PaperVitamin DAll
Causal Inference and COVID-19 Nursing Home Patients: Identifying Factors That Reduced Mortality Risk
MD Amina Ahmed, PhD Robert Goldberg, BS Joseph Swiader, MS Zachary A P Wintrob, MS Margaret Yilmaz
doi:10.1101/2021.11.18.21266489
Less than 1% of the US population lives in long-term care facilities, yet this subset of the population accounts for 22% of total COVID-19 related deaths. 1 Because of a lack of experimental evidence to treat COVID-19, analysis of real-world data to identify causal relationships between treatments/policies to mortality and morbidity among high-risk individuals is critical. We applied causal inference (CI) analysis to longitudinal patient-level health data of 4,091 long-term care high-risk patients with COVID-19 to determine if any actions or therapies delivered from January to August of 2020 reduced COVID-19 patient mortality rates during this period. Causal inference findings determined that certain supportive care interventions caused reduced mortality rates for nursing home residents regardless of severity of disease (as measured by oxygen saturation level, presence of pneumonia and organ failure), comorbidities or social determinants of health such as race, age, and weight. 2 While we do not address the biological mechanisms associated with specific medical interventions and their impact on mortality, this analysis suggests methods to validate and optimize treatment protocols using domain knowledge and causal inference analysis of real-world data across patient populations and care settings.
References
Arabi, Gordon, Derde, Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial, Intensive Care Med, doi:10.1007/s00134-021-06448-5
Bagchi, Mak, Li, Rates of COVID-19 Among Residents and Staff Members in Nursing Homes -United States, May 25, MMWR Morb Mortal Wkly Rep, doi:10.15585/mmwr.mm7002e2externalicon
Balzer, Petersen, Van Der Laan, Search Collaboration, Targeted estimation and inference for the sample average treatment effect in trials with and without pair-matching, Stat Med, doi:10.1002/sim.6965
Bareinboim, Pearl, Causal inference and the data-fusion problem, Proc Natl Acad Sci U S A, doi:10.1073/pnas.1510507113
Hager, Tsiatis, Davidian, Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data, Biometrics, doi:10.1111/biom.12894
Kosar, White, Feifer, COVID-19 Mortality Rates Among Nursing Home Residents Declined from March to November 2020, Health Aff (Millwood), doi:10.1377/hlthaff.2020.02191
Mackenzie, Race, COVID Mortality, and Simpson's Paradox
Mohan, Pearl, Graphical Models for Processing Missing Data, Journal of the American Statistical Association, doi:10.1080/01621459.2021.1874961
Oprescu, Syrgkanis, Wu, Orthogonal Random Forest for Causal Inference
Pearl, On the Testability of Causal Models with Latent and Instrumental Variables
Pearl, The seven tools of causal inference, with reflections on machine learning, Communications of the ACM, doi:10.1145/3241036
Pedregosa, Scikit-learn: Machine Learning in Python, JMLR
Prosperi, Guo, Sperrin, Causal inference and counterfactual prediction in machine learning for actionable healthcare, Nat Mach Intell, doi:10.1038/s42256-020-0197-y
Prosperi, Guo, Sperrin, Causal inference and counterfactual prediction in machine learning for actionable healthcare, Nat Mach Intell, doi:10.1038/s42256-020-0197-y
Tarazi, Finegold, Sheingold, Samson, Zuckerman et al., COVID-19-Related Deaths And Excess Deaths Among Medicare Fee-For-Service Beneficiaries, Health Aff (Millwood), doi:10.1377/hlthaff.2020.02521
{ 'institution': [{'name': 'medRxiv'}], 'indexed': { 'date-parts': [[2021, 12, 18]], 'date-time': '2021-12-18T16:04:09Z', 'timestamp': 1639843449658}, 'posted': {'date-parts': [[2021, 11, 21]]}, 'group-title': 'Health Systems and Quality Improvement', 'reference-count': 0, 'publisher': 'Cold Spring Harbor Laboratory', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'short-container-title': [], 'accepted': {'date-parts': [[2021, 11, 21]]}, 'abstract': '<jats:title>Abstract</jats:title><jats:p>Less than 1% of the US population lives in long-term ' 'care facilities, yet this subset of the population accounts for 22% of total COVID-19 related ' 'deaths.<jats:sup>1</jats:sup> Because of a lack of experimental evidence to treat COVID-19, ' 'analysis of real-world data to identify causal relationships between treatments/policies to ' 'mortality and morbidity among high-risk individuals is critical. We applied causal inference ' '(CI) analysis to longitudinal patient-level health data of 4,091 long-term care high-risk ' 'patients with COVID-19 to determine if any actions or therapies delivered from January to ' 'August of 2020 reduced COVID-19 patient mortality rates during this ' 'period.</jats:p><jats:p>Causal inference findings determined that certain supportive care ' 'interventions caused reduced mortality rates for nursing home residents regardless of ' 'severity of disease (as measured by oxygen saturation level, presence of pneumonia and organ ' 'failure), comorbidities or social determinants of health such as race, age, and ' 'weight.<jats:sup>2</jats:sup> While we do not address the biological mechanisms associated ' 'with specific medical interventions and their impact on mortality, this analysis suggests ' 'methods to validate and optimize treatment protocols using domain knowledge and causal ' 'inference analysis of real-world data across patient populations and care settings.</jats:p>', 'DOI': '10.1101/2021.11.18.21266489', 'type': 'posted-content', 'created': { 'date-parts': [[2021, 11, 21]], 'date-time': '2021-11-21T19:25:17Z', 'timestamp': 1637522717000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'Causal Inference and COVID-19 Nursing Home Patients: Identifying Factors That Reduced ' 'Mortality Risk'], 'prefix': '10.1101', 'author': [ {'given': 'Amina', 'family': 'Ahmed', 'sequence': 'first', 'affiliation': []}, {'given': 'Robert', 'family': 'Goldberg', 'sequence': 'additional', 'affiliation': []}, {'given': 'Joseph', 'family': 'Swiader', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zachary A.P.', 'family': 'Wintrob', 'sequence': 'additional', 'affiliation': []}, {'given': 'Margaret', 'family': 'Yilmaz', 'sequence': 'additional', 'affiliation': []}], 'member': '246', 'container-title': [], 'original-title': [], 'link': [ { 'URL': 'https://syndication.highwire.org/content/doi/10.1101/2021.11.18.21266489', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 11, 24]], 'date-time': '2021-11-24T06:35:12Z', 'timestamp': 1637735712000}, 'score': 1, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 11, 21]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.1101/2021.11.18.21266489', 'relation': {}, 'published': {'date-parts': [[2021, 11, 21]]}, 'subtype': 'preprint'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit